PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas
- 21 September 2015
- journal article
- Published by Elsevier BV in Human Pathology
- Vol. 47 (1), 52-63
- https://doi.org/10.1016/j.humpath.2015.09.003
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Human Solid Tumors Contain High Endothelial Venules: Association with T- and B-Lymphocyte Infiltration and Favorable Prognosis in Breast CancerCancer Research, 2011
- T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalBritish Journal of Cancer, 2011
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast CancerJournal of Clinical Oncology, 2011
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancerBreast Cancer Research and Treatment, 2010
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast CancerJournal of Clinical Oncology, 2010
- FOXP3+ Tregs and B7-H1+/PD-1+T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapyBMC Cancer, 2008
- Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late RelapseJournal of Clinical Oncology, 2006
- Lymphoid neogenesis in chronic inflammatory diseasesNature Reviews Immunology, 2006
- The B7-H1 (PD-L1) T Lymphocyte-Inhibitory Molecule Is Expressed in Breast Cancer Patients with Infiltrating Ductal Carcinoma: Correlation with Important High-Risk Prognostic FactorsNeoplasia, 2006
- Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytesInternational Immunology, 1996